Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 47, n° 2PB
pages 172-174 (août 2002)
Doi : 10.1067/mjd.2002.107966
Multiple nevoid malignant melanomas in a patient with AIDS: The role of proliferating cell nuclear antigen in the diagnosis

Francisco Pereira, MD, Wayne Carey, MD, FRCP(C), Henry Shibata, MD, FRCS(C), FACS, Miguel N. Burnier, MD, PhD, Beatrice Wang, MD, FRCP(C)
From the Departments of Dermatology, Pathology, and Oncology, Royal Victoria Hospital, McGill University Health Centre, Montreal, Quebec, Canada. 


The rapid growth of lesions clinically resembling compound nevi in patients with HIV/AIDS should alert physicians to the possibility of malignant melanomas. Immunohistochemistry for proliferating cell nuclear antigen can be helpful in the diagnosis of these tumors. A case of multiple primary nevoid melanomas in a patient with HIV/AIDS is reported. (J Am Acad Dermatol 2002;47:S172-4.)

The full text of this article is available in PDF format.

 Supported by CNPq-Brazilian governmental institution for scientific and technological development (F.P.).

Top of the page

© 2002  The American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline